Animal Vaccines Market is Forecast to Reach a Valuation of US$ 29 Bn by 2032 – Latest Fact.MR Study

Attenuated Live Vaccines to Hold Nearly 30% of the Animal Vaccines Market

The Fact.MR market study on the animal vaccine market provides deep dive into key developments in the animal vaccine market. The report offers a comprehensive analysis of leading segments in terms of therapy type, distribution channel, and region.

Fact.MR – A Market research and competitive intelligence provider: The global sales of animal vaccines are forecast to garner a market valuation of US$ 12 Bn in 2022 and is expected to register a positive market size at a CAGR of 9.2% by accumulating a market valuation of US$ 29 Bn through the assessment period 2022-2032

Manufacturers of animal vaccines are engrossing in creating awareness regarding the importance of animal vaccination. As the food industry heavily relies on animals for milk and meat, the demand for vaccination is expected to grow in the market.

Increasing outbreaks of cattle disease and a growing livestock population are the main reasons for the wide acceptance of animal vaccination globally. As animals serve as an essential source of meat, milk, protein, food, and other commercial products such as wool and leather, keeping a track of them has become essential.

For Critical Insights on This Market, Request for More Info

https://www.factmr.com/connectus/sample?flag=S&rep_id=7123

The increasing presence of well-established pharmaceutical are aiming for wide commercialization of their vaccines and propelling their geographical reach in countries like U.S. and Canada is expected to bolster the market growth.

Growing commercial food animal production has resulted from increased demand for animal protein. Emerging zoonotic infections in companion and livestock animals pose a serious public health danger. Furthermore, the likelihood of developing disease outbreaks around the world is significant. As a result, the need for animal vaccines has skyrocketed.

Government initiatives and an increase in livestock population across India and China are expected to accelerate the growth of animal vaccines in the Asia Pacific. Moreover, a vegetarian lifestyle has increased the demand for milk and milk products.

Key takeaways:

• North America is expected to hold more than 23% market share for animal vaccines in the market.
• The Asia Pacific is expected to possess more than 20% market share for animal vaccines in the market
• By product, attenuated live vaccines are anticipated to hold more than 30% of the market share for animal vaccines.
• By animal type, Livestock is expected to hold more than 65% market share for animal vaccines in the market.

Growth Drivers:

• An increase in concern for food security and growth in animal husbandry are stimulating the demand for animal vaccines for the livestock population.
• An increase in the outbreak of disease amongst cattle along with canine disorders is boosting the sales of animal vaccines in the market.

To gain in-depth insights on the Animal Vaccine Market, request methodology at:

https://www.factmr.com/connectus/sample?flag=RM&rep_id=7123

Competitive Landscape:

The competitive landscape of the Animal Vaccine Market focuses on Food and clothing industry largely depends on animals for milk, meat, and wool. Thus, animal safety has become important.

• In August 2020, Merck & Co., Inc. completed the acquisition of IdentiGEN. The company is focusing on studying the DNA of animals for livestock. Through this acquisition, Merck intends to provide complete transparency to food processors, producers, and retailers, regarding animal traceability solutions to ensure that good quality food is available to consumers
• In January 2022, Zoetis Inc. announced that the U.S Food and Drug Administration has approved SolensiaTM (frunevetmab injection) to control the pain of osteoarthritis in cats, helping improve their mobility, comfort, and overall well-being.

More valuable insights on the Animal Vaccine Market:

Fact.MR, in its report, offers a market analysis of the global Animal Vaccine Market the forecast period through 2022 and beyond. This survey reveals the growth of Healthcare in the Animal vaccine Market with detailed segmentation as follows

• By Product
  • Attenuated Live Animal Vaccines
  • Recombinant Animal Vaccines
  • DNA Animal Vaccines
  • Inactivated Animal Vaccines
  • Subunit Animal Vaccines
• By Animal Type
  • Livestock Animal Vaccines
    • Poultry
    • Ruminants
    • Swine
    • Aqua
  • Companion Animal Vaccines
    • Canine
    • Feline
    • Others
• By Route of Administration
  • Subcutaneous Administration of Animal Vaccines
  • Intranasal Administration of Animal Vaccines
  • Intramuscular Administration of Animal Vaccines

Key Questions covered in the Animal Vaccine Market Report

How much is the animal vaccines industry likely to be worth?

At what rate will the animal vaccines industry grow from 2022- 2032?

How much is the animal vaccines market like to be valued by 2032?

What was the growth rate of the market for animal vaccines from 2015- 2021?

What was the recorded market value for animal vaccines in 2021?

Explore Fact.MR’s Coverage on the Healthcare Domain-

Vaccine Delivery Devices Market scope: The increasing demand for needle-free products to avoid pain and injuries associated with vaccination is expected to boost the industry in the forecast period.

Vaccine Delivery Devices Market analysis: The market is primarily driven by the increasing immunization programs, growing vaccination initiatives & campaigns, and the rising incidences of diseases across the globe.

Auto Disable Syringes Market trends: The risk of infection and transmission of deadly ailments such as blood-borne diseases, HIV, viral hepatitis, and others is the prime driver of the global auto-disable syringes market.

BHK Rabies Vaccine Market forecast: The BHK baby hamster kidney cell line is also called embryo hamster cell line which is isolated from 1-day old hamsters These BHK rabies vaccines are widely used as they are lower in terms of their production cost and large cell quantity is obtained.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & chemical and materials, our coverage is expansive, but we ensure even the most niche categories are analysed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

Source: Fact.MR